Egertova¤ , M., Elphick, M.R., 2000. Localization of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of
CB1. J. Comp. Neurol. 442, 159^171.
Ha¤jos, N., Katona, I., Naiem, S.S., Mackie, K., Ledent, C., Mody, I., Freund, T.F., 2000. Cannabinoids inhibit hippocampal GABAergic
transmission and network oscillations. Eur. J. Neurosci. 12, 3239^3249.
Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R., Rise, K.C., 1991. Characterization and localization of cannabinoid
receptors in rat brain : a quantitative in vitro radiographic study. J. Neurosci. 11, 563^583.
Hohmann, A.G., Herkenham, M., 2000. Localization of cannabinoid CB (1) receptor mRNA in normal subpopulations of rat striatum : a doublelabel in situ hybridization study. Synapse 37, 71^80.
Jancso¤ , G., Kira¤ ly, E., 1981. Sensory neurotoxins : chemically induced selective destruction of primary sensory neurons. Brain Res. 210, 83^89.
Jancso¤ , G., Kira¤ ly, E., Jancso¤ -Ga¤ bor, A., 1977. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons.
Nature 270, 741^743.
Joo¤ , F., Szolcsa¤ nyi, J., Jancso¤ -Ga¤ bor, A., 1969. Mitochondrial alterations in the spinal ganglion cells of the rat accompanying the long-lasting
sensory disturbance induced by capsaicin. Life Sci. 8, 621^626.
Katona, I., Sperla¤ gh, B., Sik, A., Ko« falvi, A., Vizi, E.S., Mackie, K., Freund, T.F., 1999. Presynaptically located CB1 cannabinoid receptors
regulate GABA release from axonal terminals of speci¢c hippocampal interneurons. J. Neurosci. 19, 4544^4558.
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Bo« hme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G.,
Fratta, W., Parmentier, M., 1999. Unresponsiveness to cannabinoids and reduced addictive e¡ects of opiates in CB1 receptor knockout mice.
Science 283, 401^404.
Lieberman, A.R., 1976. Sensory ganglia. In : Landon, D.N. (Ed.), The Peripheral Nerve. Chapman and Hall, London, pp. 178^188.
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., Finazzi-Agro, A., 2000. Anandamide induces apoptosis in human cells via vanilloid
receptors ^ evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275, 31938^31945.
Mezey, EŁ ., To¤ th, Z.E., Cortright, D.N., Arzubi, M.K., Krause, J.E., Elde, R., Guo, A., Blumberg, P.M., Sza¤ lla¤ si, AŁ ., 2000. Distribution of mRNA
for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad.
Sci. USA 97, 3655^3660.
Richardson, J.D., Kilo, S., Hargreaves, K.M., 1998. Cannabinoids reduce hyperalgesia and in£ammation via interaction with peripheral CB1
receptors. Pain 75, 111^119.
Ross, R.A., Gibson, T.M., Brockie, H.C., Leslie, M., Pashmi, G., Craib, S.J., Di Marzo, V., Pertwee, R.G., 2001. Structure-activity relationship
for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and was deferens. Br.
J. Pharmacol. 132, 631^640.
Smart, D., Gunthorpe, M.J., Jerman, J.C., Nasir, S., Gray, J., Muir, A.I., Chambers, J.K., Randall, A.D., Davis, J.B., 2000. The endogenous lipid
anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129, 227^230.
Smart, D., Jerman, J.C., 2000. Anandamide : an endogenous activator of the vanilloid receptor. Trends Pharmacol. Sci. 21, 134.
Sugimoto, T., Xiao, C., Ichikawa, H., 1998. Neonatal primary neuronal death induced by capsaicin and axotomy involves an apoptotic mechanism. Brain Res. 807, 147^154.
Sza¤lla¤si, A., Blumberg, P.M., 1999. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51, 159^211.
Sza¤ lla¤ si, A., Di Marzo, V., 2000. New perspectives on enigmatic vanilloid receptors. Trends Neurosci. 23, 491^497.
Sza¤ lla¤ si, A., Joo¤ , F., Blumberg, P., 1989. Duration of desensitization and ultrastructural changes in dorsal root ganglia of rats treated with
resiniferatoxin, an ultrapotent capsaicin analog. Brain Res. 503, 68^72.
Szoke, EŁ ., Balla, Zs., Csernoch, L., Cze¤h, G., Szolcsa¤nyi, J., 2000. Interacting e¡ects of capsaicin and anandamide on intracellular calcium in
sensory neurons. NeuroReport 11, 1949^1952.
Szo‹ ke, EŁ ., Seress, L., Szolcsa¤ nyi, J., 1998. Reevaluation of the neurotoxic e¡ect of neonatal capsaicin treatment on the basis of morphometrical
studies. Neurobiology 6, 477^478.
Szo‹ ke, EŁ ., Seress, L., Szolcsa¤ nyi, J., 2002. Neonatal capsaicin treatment results in prolonged mitochondrial damage and delayed cell death of B cells
in the rat trigeminal ganglia. Neuroscience 113, 925^937.
Szolcsa¤nyi, J., 1993. Actions of capsaicin on sensory receptors. In: Wood, J. (Ed.), Capsaicin in the Study of Pain. Academic, London, pp. 1^26.
Szolcsa¤nyi, J., 2000a. Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol. Sci. 21, 41^42.
Szolcsa¤nyi, J., 2000b. Anandamide and the question of its functional role for activation of capsaicin receptors. Trends Pharmacol. Sci. 21, 203^204.
Szolcsa¤ nyi, J., Jancso¤ -Ga¤ bor, A., Joo¤ , F., 1975. Functional and ¢ne structural characteristics of the sensory neuron blocking e¡ect of capsaicin.
Naunyn^Schmiedeberg's Arch. Pharmacol. 287, 157^169.
Szolcsa¤ nyi, J., Joo¤ , F., Jancso¤ -Ga¤ bor, A., 1971. Mitochondrial changes in preoptic neurons after capsaicin desensitization of the hypothalamic
thermodetectors in rats. Nature 299, 116^117.
Szolcsa¤ nyi, J., Sza¤ lla¤ si, A., Sza¤ lla¤ si, Z., Joo¤ , F., Blumberg, P.M., 1990. Resiniferatoxin : an ultrapotent selective modulator of capsaicin-sensitive
primary a¡erent neurons. J. Pharmacol. Exp. Ther. 255, 923^928.
Szolcsa¤ nyi, J., Szo‹ ke, EŁ ., Seress, J., 1998. Reevaluation of the neurotoxic e¡ect of neonatal capsaicin treatment on rat's trigeminal sensory neurons.
Soc. Neurosci. Abstr. 24, 229.
Tominaga, M., Caterina, M.J., Malmberg, A.B., Rosen, T.A., Gilbert, H., Skinner, K., Baumann, B.E., Basbaum, A.I., Julius, D., 1998. The
cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21, 531^543.
Zygmunt, P.M., Julius, D., Di Marzo, V., Ho«gesta«tt, E.D., 2000. Anandamide ^ the other side of the coin. Trends Pharmacol. Sci. 21, 43^44.
Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H-h., S rgafi rd, M., Di Marzo, V., Julius, D., Ho« gesta« tt, E.D., 1999. Vanilloid receptors
on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452^457.
